Last reviewed · How we verify

NCT07317453

Precise Image for Musculoskeletal CT

Not yet recruiting Last updated 5 January 2026
What this trial tests

trial in Computed Tomography in 84 participants. Not yet recruiting.

Timeline
31 January 2026
Primary endpoint
1 September 2026
1 October 2026

Quick facts

Lead sponsorPhilips Clinical & Medical Affairs Global
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment84
Start date31 January 2026
Primary completion1 September 2026
Estimated completion1 October 2026

Conditions studied

Sponsor

Philips Clinical & Medical Affairs Global — full company profile →

Who can join

18 and older, any sex, with Computed Tomography. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this clinical study is to evaluate the performance of the Precise Image reconstruction algorithm for musculoskeletal CT imaging (shoulder, hip, knee) of adult patients (\>18 years old). Clinical data generated from this study is intended to support a proposed expansion of the Indications for Use of Precise Image. The study has two objectives: 1. To evaluate the image quality and diagnostic confidence of Precise Image compared to the standard-of-care reference (iDose4) for: * Musculoskeletal CT images (shoulder, hip, knee) of adult patients (\>18 years old). 2. To demonstrate non-inferiority of Precise Image to iDose4 for the relevant resolution groups.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Computed Tomography

Currently open trials in the same condition.

Other Philips Clinical & Medical Affairs Global trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07317453.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing